Brazil has one of the fastest growing pharmaceutical markets in the world. It is driven by an increasing disease burden and high affordability. However, a decrease in foreign investment and increased government promotion of generic drugs are barriers to growth. The value of the market was US$25.3 Billion in 2016, having increased from US$15.4 Billion in 2009 at a Compound Annual Growth Rate (CAGR) of 3.4%. Changing demographics are an important driver for the market, as the increasingly elderly population will lead to an increase in the incidence of chronic and other lifestyle-associated diseases. The growing middle class, who have high purchasing power, is another major driver.
Brazil’s medical device market was valued at US$7.1 Billion in 2009 and US$9.7 Billion in 2016. It is projected to grow at a CAGR of 6.4% from US$10.9 Billion in 2017 to US$14 Billion in 2021. In 2016, In Vitro Diagnostics (IVD) accounted for 11.5% of the medical device market, followed by orthopedic devices (10.8%), diagnostic imaging (10.6%), ophthalmic devices (8.8%) and cardiovascular devices (8.7%).
Most hospitals in Brazil offer primary care services exclusively. In 2016, health expenditure accounted for 8.2% of GDP, having accounted for 8.6% in 2009. Brazilian hospitals have inadequate resources and are thereby unable to provide access to healthcare provisions for every citizen, especially to those in weaker economic sections.
Brazil entered a period of recession in 2015. The economy contracted by 3.6% in 2016. This was due to a fall in commodity prices and political instability that led to a decline in investor confidence. This was augmented by the Chinese economic slowdown, which led to reduced demand for commodities and the corruption scandals involving government officials and major companies. In August 2016, following mass nationwide protests, President Rousseff was impeached on charges of breaking budgetary laws and the incumbent vice president Michel Temer took over.
The report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil” an overview of the pharmaceutical and medical device market of Brazil, including the market size; market segmentation by generic, Over-The-Counter (OTC), biologic and biosimilar products; and the key drivers and barriers for the market.
In depth, this report provides the following analysis –
- Covers the country’s reimbursement and payer landscape, as well as the regulatory landscape. The reimbursement and payer landscape section elaborates on the features of the healthcare reimbursement process for Brazil.
- Provides a detailed analysis of the political and economic environment of Brazil. It analyzes its economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- Provides an overview of the opportunities and challenges for growth that exist in the healthcare market of Brazil.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes –
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Hypermarcas, Roche, Novartis and Sanofi and Profiles and SWOT analyses of the major players in the medical device market: Johnson & Johnson, B.Braun, Medtronic, Baxter and GSK.
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Brazil healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to –
- Develop business strategies by understanding the trends shaping and driving Brazil’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Brazil’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership